US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Accustem Sciences Inc.

0.1336

-0.0138-9.39%

Volume:356

Turnover:47.56

Market Cap:2.15M

PE:-1.30

High:0.1336

Open:0.1336

Low:0.1336

Close:0.1475

52wk High:1.34

52wk Low:0.1170

Shares:16.07M

Float Shares:7.89M

Volume Ratio:16.79

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1029

ROE:-1794.16%

ROA:-64.16%

PB:-0.52

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Accustem Sciences Inc.

Exchange:

OTCQB

Establishment Date:

2013

Employees:

4

Office Location:

5 Penn Plaza,19th Floor,#1954,New York,New York,United States

Website:

- -

Zip Code:

10001

Phone:

- -

Fax:

- -

Introduction:

AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/ACUT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","market":"US","secType":"STK","nameCN":"Accustem Sciences Inc.","latestPrice":0.1336,"timestamp":1792699200000,"preClose":0.14745,"halted":0,"volume":356,"delay":15,"changeRate":-0.09393014581213972,"floatShares":7885954,"shares":16072267,"eps":-0.102871,"marketStatus":"Post-Mkt","change":-0.01385,"latestTime":"10-22 16:00:00 EDT Delay","open":0.1336,"high":0.1336,"low":0.1336,"amount":47.5616,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.102871,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792713600000},"marketStatusCode":4,"adr":0,"exchange":"OTCQB","adjPreClose":0.14745,"volumeRatio":16.792445},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUT\",,,,,undefined,":{"symbol":"ACUT","floatShares":7885954,"roa":"-64.16%","roe":"-1794.16%","lyrEps":0,"volumeRatio":16.792445,"shares":16072267,"dividePrice":0,"high":0.1336,"amplitude":0,"preClose":0.14745,"low":0.1336,"week52Low":0.117,"pbRate":"-0.52","psRate":"21.82","week52High":1.34,"institutionHeld":0,"latestPrice":0.1336,"eps":-0.102871,"divideRate":0,"volume":356,"delay":15,"ttmEps":-0.102871,"open":0.1336,"prevYearClose":0.81351,"prevWeekClose":0.1474,"prevMonthClose":0.135,"prevQuarterClose":0.135,"fiveDayClose":0.1474,"twentyDayClose":0.12,"sixtyDayClose":0.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-16","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1726459200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-20","symbol":"ACUT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1716177600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":669855648,"yearFounded":2013,"employeeNum":4,"address":"5 Penn Plaza,19th Floor,#1954,New York,New York,United States","zipCode":"10001","fiscalYearEnd":"12-30"},"stockCompanyDetail":{"description":"AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers. Its primary product candidate is StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company was founded in 2013 and is headquartered in New York, New York.","exchange":"OTCQB","name":"Accustem Sciences Inc.","nameEN":"Accustem Sciences Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUT\",market:\"US\",,,undefined,":null}}